Regard Hits Milestone of Catching Five Million Medical Conditions

Leading clinical insights platform names new advisory board

LOS ANGELES, Feb. 11, 2025 /PRNewswire/ — Regard, the leading clinical insights platform empowering clinicians to unlock the full potential of patient data, announced today it has surpassed five million diagnoses. Regard analyzes the entire medical record to recommend diagnoses that underpin its proactive documentation for clinicians.

In this data-driven era, physicians are facing data overload, increasing the risk of errors and making it harder to provide personalized and accurate care. According to recent research published in JAMA, nearly 800,000 people die or are permanently disabled each year due to diagnostic errors made in clinical settings. Even the most skilled physicians don’t have enough time to pour through the data and documentation in the EHR before seeing a patient, making it easier to miss a critical diagnosis.

In the last year, Regard has more than doubled the number of diagnoses accepted by physicians since announcing two million patient diagnoses in January 2024, with the last one million occurring in just three months. Health systems utilizing Regard’s technology saw more than a 10 percent increase in comorbidities (CC) and major comorbidities (MCC) captured. By identifying and flagging these diagnoses for physicians to further investigate and ultimately approve or not, Regard’s technology ensures hospitals have a full picture of a patient’s health, protects revenue, and most importantly catches potential safety issues all while allowing the physician to retain full control over diagnosis and treatment.

“Regard empowers doctors by enabling them to easily harness the data in the EHR. When that happens, medical care improves,” said Eli Ben-Joseph, Regard CEO and Co-Founder. “I’m excited to see this growth curve continue as we expand our team and product and help physicians unlock the full power of the EHR.”

Amidst this major diagnosis milestone, Regard has named four members to its advisory board who will assist Regard in its mission to ensure every patient receives the highest quality care. These founding members have extensive and impressive experience in the healthcare, technology, and growth strategies field, and will provide a wealth of knowledge as the company accelerates growth and product development.

The members are:

“Clinical documentation is critical for clinicians and health systems, and Regard does the heavy lifting by identifying all diagnoses from lab, pathology and radiology — including now more than 5 million that were previously undocumented in the medical record,” said Mark Laret, former President & CEO of UCSF Health and a member of Regard’s board of directors. “By immediately creating actionable notes in the medical record, improving work flow for clinicians and appropriately driving health system quality scores and reimbursement, Regard is reducing workload and helping address physician burnout.”

About Regard

Regard, the leading AI clinical insights platform, unlocks the full potential of patient data.  Regard’s proactive documentation platform enables the future of healthcare by augmenting clinical workflows and turning data into actionable insights. The technology helps health systems get the most value out of their clinical data: improving patient care, saving physicians time, and rejuvenating hospital finances. Regard is carving a path forward for health systems and physicians to meaningfully leverage AI, with the goal of empowering physicians to provide world-class healthcare to everyone.

Media contact:

Kara Spak
kara@12080group.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/regard-hits-milestone-of-catching-five-million-medical-conditions-302373503.html

SOURCE Regard

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

44 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

44 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

4 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

5 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

19 hours ago